Use of CPETarm for Risk Stratification of Patients With CLTI
Use of CPETarm for Risk Stratification of Patients With CLTI
Not yet recruiting · NCT06404229 · Registry updated 2024-05-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Use of CPETarm for Risk Stratification of Patients With CLTI | Arterial Occlusive Diseases, Chronic Disease, Chronic Limb-Threatening Ischemia, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, ischemic disease, peripheral arterial disease, peripheral vascular disease, vascular disorder | Not yet recruiting | Not applicable | 2024-05-08 | NCT06404229 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Manchester | 85 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Manchester | Manchester | United Kingdom | 1 |